Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients with atrial fibrillation (AF) and ...
Hosted on MSN
Lack of benefit from left atrial appendage occlusion for some patients after valvular surgery
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
MARLBOROUGH, Mass., May 22, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the OPTION trial to compare safety and effectiveness of the next-generation WATCHMAN FLX™ left ...
The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...
Baptist Heart & Vascular Institute cardiologists, advanced practice providers and BHVI leadership recently gathered to celebrate the performance of its 1,000th Watchman procedure. The procedure is a ...
Demonstrated to significantly reduce stroke compared to warfarin, Pradaxa is first new oral anticoagulant approved by the FDA in more than 50 years RIDGEFIELD, Conn., Oct. 20 /PRNewswire/ -- The U.S.
When David Reed was first diagnosed with atrial fibrillation (AFib), the treatment felt more unsettling than the disease. The most common form of heart arrhythmia, AFib prompts the heart’s upper ...
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...
If you don’t know someone who has experienced Atrial Fibrillation, commonly referred to as AFib, odds are you will at some point. Estimates show up to 12 million people may be affected by AFib by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results